npj Breast Cancer旨在推动乳腺癌领域的科学进步。目前,该期刊处于中科院二区,IF5.9,国人占比7.8%,审稿周期可能稍长,但该期刊在以前的年份曾是TOP期刊,所以有一定实力,投稿指数四颗星。 SCI晚发1天,创新就有被抢的风险! 免费匹配录用方案 2个月就录用
npj Breast Cancer杂志仅支持在线发表,属于Open Access杂志,由Nature杂志社与乳腺癌研究基金会(BCRF)共同出版。数据为WOS、MEDLINE等数据库所收录。 该杂志主编Larry Norton,是美国著名的纪念斯隆凯特林癌症中心(Memorial Sloan-Kettering Cancer Center;MSKCC)教授。他在学术界享有很高的声誉,也是一位优秀的“高被引”科...
From: If we build it they will come: targeting the immune response to breast cancer Interaction between the innate and adaptive immune system is vital for immune recognition and elimination of breast tumors. Activation of antigen presenting cells, natural killer cells, macrophages and engagement of ...
《Npj Breast Cancer》是一本由Springer Nature出版的Medicine-Pharmacology (medical)学术刊物,主要刊载Medicine-Pharmacology (medical)相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于2015年
If we build it they will come: targeting the immune response to breast cancer Margaret E. Gatti-Mays, Justin M. Balko, Sofia R. Gameiro, Harry D. Bear, Sangeetha Prabhakaran, Jami Fukui, Mary L. Disis, Rita Nanda, James L. Gulley, Kevin Kalinsky, Houssein Abdul Sater,...
TME differences among various mouse models of pancreatic cancer, and the mechanisms underlying resistance to immunotherapeutic interventions. Furthermore, we discuss the potential of targeting cancer cell-intrinsic pathways and TME components to sensitize PDAC to immune therapies, providing insights into stra...
breast cancer (BRCA) and head and neck squamous cell carcinoma (HNSC) (Fig.8A, B). However, in clear cell renal cell carcinoma (KIRC), the expression of IFN-γ is unfavorable for patient prognosis (Fig.8C). In low-grade glioma (LGG), ovarian cancer (OV), and sarcoma (SARC), the...
该杂志综合评价:npj Breast Cancer是一本定位中高端的杂志,估计明年起第一个影响因子会突破5分,可谓是乳腺癌的一颗新星,该方向的同学们可以一试。 参考文献: http://apps.webofknowledge.com/ https://mp.weixin.qq.com/s/gyMIyaC4u40eHK2iCD2aBA ...
npj breast cancer npj parkinsons disease npj precision oncology npj regenerative medicine 1、npj 2d materials and applications 发文量,2017年是37篇,2018年是34篇。即时影响因子计算发现,2020年1月2日,8.901分。按照往年经验,在2020年6月份公布的IF中,它在9.95~10.85分之间!!
Subclonal heterogeneity and evolution are characteristics of breast cancer that play a fundamental role in tumour development, progression and resistance to current therapies. In this review, we focus on the recent advances in understanding the epigeneti